CNO Financial officer plans sale of 4,362 shares

Officer Jeremy David Williams filed a Rule 144 notice to sell 4,362 CNO shares, following a prior 4,420-share sale in the past three months.

Available on EDGAR 09/16/2026 - 04:41 PM EDT Accepted by SEC EDGAR 09/16/2026 - 04:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) received a notice that officer Jeremy David Williams intends to sell Common Stock under Rule 144. The notice covers 4,362 shares with an aggregate market value of $243,029.65, relative to 92,521,371 shares outstanding, with sales expected to begin on September 16, 2026. The shares to be sold include 1,122 shares from performance shares acquired on February 10, 2026 and 3,240 shares from a stock option exercise on September 16, 2026. Williams previously sold 4,420 shares on June 15, 2026 for $244,291.63.

Key Figures

Shares to be sold under Rule 144: 4,362 shares Aggregate market value of shares to be sold: $243,029.65 Shares outstanding: 92,521,371 shares +4 more

7 metrics

Shares to be sold under Rule 144 4,362 shares Planned sale of CNO Common Stock by officer Jeremy David Williams

Aggregate market value of shares to be sold $243,029.65 Value of 4,362 CNO shares covered by the Rule 144 notice

Shares outstanding 92,521,371 shares CNO Common Stock outstanding referenced in the notice

Shares from Performance Shares 1,122 shares Common Stock underlying performance shares acquired February 10, 2026

Shares from Stock Option Exercise 3,240 shares Common Stock from options exercised September 16, 2026

Recent shares sold 4,420 shares CNO shares sold by Jeremy Williams on June 15, 2026

Proceeds from recent sale $244,291.63 Total consideration for 4,420 CNO shares sold in past three months

Key Terms

Rule 144, Performance Shares, Stock Option Exercise

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 02/10/2026 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Stock Option Exercise financial

"Common | 09/16/2026 | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CNO Financial Group (CNO)?

It discloses that officer Jeremy David Williams plans to sell 4,362 shares of CNO Common Stock under Rule 144, with an aggregate market value of $243,029.65 and an approximate sale date of September 16, 2026 on the NYSE.

How many CNO (CNO) shares are outstanding as referenced in this Form 144?

The notice lists 92,521,371 shares of CNO Common Stock as outstanding in connection with the planned Rule 144 sale of 4,362 shares by officer Jeremy David Williams.

What types of CNO (CNO) awards are the shares being sold derived from?

The planned sales relate to 1,122 shares from Performance Shares acquired on February 10, 2026 and 3,240 shares from a Stock Option Exercise on September 16, 2026, all in CNO Common Stock.

What CNO (CNO) stock sales has Jeremy Williams made in the past three months?

Over the past three months, Jeremy Williams sold 4,420 shares of CNO Common Stock on June 15, 2026 for total proceeds of $244,291.63, as disclosed in the Form 144 notice.

Which broker is involved in the planned CNO (CNO) Rule 144 sale?

The notice identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker handling the planned Rule 144 sale of CNO Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006641
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CNO FINANCIAL GROUP, INC.
SEC File Number	001-31792
Address of Issuer	11299 Illinois Street Carmel INDIANA 46032
Phone	(317) 817-6100
Name of Person for Whose Account the Securities are To Be Sold	JEREMY WILLIAMS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4362	243029.65	92521371	09/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Performance Shares	ISSUER			1122	02/10/2026	Not Applicable
Common	09/16/2026	Stock Option Exercise	ISSUER			3240	09/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEREMY WILLIAMS 11299 Illinois Street Carmel IN 46032	Common	09/15/2026	4420	244291.63

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeremy David Williams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)